Schayan Yousefian

7PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Proteomics and intermolecular interactions (excl. medical proteomics)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2026
A distinct CAR-T cell phenotype mediates therapeutic response at limited doses.

|Oct 20, 2025
Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy.

M Korenkov, J Liebaert, S Yousefian

|Aug 07, 2025
Ultra-high-scale cytometry-based cellular interaction mapping.

Dominik Vonficht, Lea Jopp-Saile, Schayan Yousefian

|Nov 29, 2024
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy.

Raphael Lutz, Florian Grünschläger, Malte Simon

|Nov 26, 2024
Aggressive Lymphoma after CD19 CAR T-Cell Therapy.

Guido Kobbe, Monika Brüggemann, Ben-Niklas Baermann

|Aug 27, 2024
Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study.

Patrick Derigs, Maria-Luisa Schubert, Peter Dreger

Pageof 2

Frequent Collaborators

5 joint publications

Simon Haas

3 joint publications

Daniel Hübschmann

3 joint publications

Carsten Müller-Tidow

3 joint publications

Ulrich Keller